Understanding Gut Leakage in Dengue Fever
Part of Digestive system, Infections clinical trials.
This study investigates whether dengue fever causes the intestinal lining to become leaky, allowing harmful substances to enter the bloodstream. Researchers compare blood markers in dengue patients and healthy volunteers to understand how this happens and why it might make dengue worse.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- For dengue patients: hospitalized within the last 24 hours with confirmed dengue (positive NS1 antigen or IgM antibody test)
- For healthy volunteers: be a family member or attendant of a dengue patient with no current illness
- No chronic gut, liver, or heart conditions that affect how your intestines work
- Have not taken metformin, statins, probiotics, or steroids in the 48 hours before enrollment
- Not pregnant, not immunosuppressed (no chemotherapy or high-dose steroids), and no advanced kidney disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests new medicines for people hospitalized with moderate-to-severe dengue fever. Dengue is a mosquito-borne virus that can cause serious complications like severe bleeding, organ damage, or shock. The trial aims to find treatments that help patients recover faster and avoid life-threatening complications.
This study looks at how the immune system responds to dengue fever and sepsis (a severe infection). It aims to better understand these illnesses, which could lead to improved treatments. If you have dengue-like symptoms, sepsis, or are a healthy volunteer, you may be able to join.
This trial tests how the dengue virus affects healthy adults who have never been exposed to dengue or similar viruses. You would be given a controlled dose of the virus and closely monitored to help researchers understand the infection and develop better treatments or vaccines.
This study looks at why some people with dengue need to be hospitalized or get a blood transfusion. It aims to make care safer and help doctors know who needs closer monitoring.
This study tests a controlled dengue infection in people who already have immunity to some types of dengue. It aims to understand how the immune system responds and to help develop better vaccines. You may qualify if you are a healthy adult aged 18-40 and have evidence of prior dengue exposure to certain virus types.
This study tests how the body responds to a mild, lab-made dengue virus in people who have had dengue before. It looks at how the immune system reacts to a second infection, which may help improve future vaccines and treatments.
Hear when a new Dengue trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.